Respiratory Syncytial Virus (RSV) Treatment Study
Now Enrolling in Edmond and Yukon
Investigational Treatment Study
Tekton Research is seeking adult volunteers (18+) to participate in an Investigational Respiratory Syncytial Virus (RSV) Treatment Study.
You may be eligible to take part if you:
- Are age 18 years of age or older
- Have had a positive RSV infection within the last 5 days
- Have had any other positive respiratory infection including Flu or COVID-19 within the last 7 days
What is RSV?
RSV is a common respiratory virus that infects the lungs and breathing passages. People most often associate RSV with the risk it brings to young children, but not many know the high risk it poses for older adults. There are currently no approved treatments or vaccines for RSV.
Severe RSV infection is unpredictable and can be dangerous for certain adults, such as adults 50 years and older, those with chronic heart or lung disease, or those with a weakened immune system.
Why Tekton?
Tekton Research is a clinical research site that conducts clinical studies with the primary focus on improving the quality of life for all.
We work with pharmaceutical and device companies to help bring new and more effective medications to those who need them. We conduct studies with deliberate concentration on knowledge, skills and integrity.
Here at Tekton, our staff ensures that every potential and current study participant is accurately qualified for the most appropriate study based on criteria.
